Published in Proc Natl Acad Sci U S A on July 23, 1996
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol (2000) 2.21
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol (2008) 1.52
Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol (2006) 1.45
Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol (2002) 1.36
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol (2006) 1.14
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces (2011) 1.14
Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol (2006) 1.11
Hyaluronan and tumor growth. Am J Pathol (2002) 1.03
The design and application of fluorophore-gold nanoparticle activatable probes. Phys Chem Chem Phys (2011) 1.01
Activatable molecular probes for cancer imaging. Curr Top Med Chem (2010) 0.97
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials (2012) 0.96
Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. BMC Cancer (2009) 0.96
Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression. Int J Cancer (2010) 0.93
Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis. PLoS One (2011) 0.91
Elimination of autofluorescence in fluorescence correlation spectroscopy using the AzaDiOxaTriAngulenium (ADOTA) fluorophore in combination with time-correlated single-photon counting (TCSPC). Anal Bioanal Chem (2013) 0.91
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer (2010) 0.90
Fluorescence detection of hyaluronidase. J Photochem Photobiol B (2011) 0.89
Expression of hyaluronan in human tumor progression. J Carcinog (2006) 0.88
Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid. Biomaterials (2010) 0.88
Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH. Arthritis Res Ther (2005) 0.87
Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues. J Biol Chem (2009) 0.86
The effect of hyaluronic Acid on the invasiveness of malignant glioma cells : comparison of invasion potential at hyaluronic Acid hydrogel and matrigel. J Korean Neurosurg Soc (2009) 0.86
Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells. J Drug Deliv (2013) 0.85
Lifetime-based sensing of the hyaluronidase using fluorescein labeled hyaluronic acid. J Photochem Photobiol B (2011) 0.83
N-glycosylation is required for secretion and enzymatic activity of human hyaluronidase1. FEBS Open Bio (2014) 0.82
Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer (2013) 0.82
Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine. Ann Biomed Eng (2013) 0.82
Serum hyaluronidase aberrations in metabolic and morphogenetic disorders. Glycoconj J (2005) 0.81
SPAM1 (PH-20) protein and mRNA expression in the epididymides of humans and macaques: utilizing laser microdissection/RT-PCR. Reprod Biol Endocrinol (2003) 0.81
Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7. Clin Dev Immunol (2013) 0.80
Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model. J Mater Sci Mater Med (2013) 0.80
Detection of hyaluronidase activity using fluorescein labeled hyaluronic acid and Fluorescence Correlation Spectroscopy. J Photochem Photobiol B (2012) 0.79
Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis. Clin Exp Metastasis (1998) 0.77
Therapeutic effects of tyroservatide on metastasis of lung cancer and its mechanism affecting integrin-focal adhesion kinase signal transduction. Drug Des Devel Ther (2016) 0.76
A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx. PLoS One (2010) 0.76
Hyaluronidases and hyaluronan synthases expression is inversely correlated with malignancy in lung/bronchial pre-neoplastic and neoplastic lesions, affecting prognosis. Braz J Med Biol Res (2015) 0.75
Double-layered hyaluronic acid/stearic acid-modified polyethyleneimine nanoparticles encapsulating (-)-gossypol: a nanocarrier for chiral anticancer drugs. J Mater Chem B Mater Biol Med (2014) 0.75
Hyaluronan synthase control of synthesis rate and hyaluronan product size are independent functions differentially affected by mutations in a conserved tandem B-X7-B motif. Glycobiology (2016) 0.75
Hyaluronic acid in digestive cancers. J Cancer Res Clin Oncol (2016) 0.75
Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol (1993) 6.53
The pathogenesis of cancer metastasis. Nature (1980) 5.74
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res (1986) 5.05
The matrix-degrading metalloproteinases. Bioessays (1992) 4.84
Proteoglycans as modulators of growth factor activities. Cell (1991) 4.45
Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol (1983) 3.60
Angiogenesis induced by degradation products of hyaluronic acid. Science (1985) 3.37
Cell culture of human colon adenomas and carcinomas. Cancer Res (1987) 2.68
Structure and biology of proteoglycans. Annu Rev Cell Biol (1988) 2.63
Tumor angiogenesis. Adv Cancer Res (1974) 2.38
Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol (1990) 1.84
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (1983) 1.63
The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Curr Opin Cell Biol (1990) 1.54
CD44 splice variants: metastases meet lymphocytes. Immunol Today (1993) 1.50
The role of hyaluronan in tumour neovascularization (review). Int J Cancer (1995) 1.40
Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol (1994) 1.38
Hyaluronate in vasculogenesis. Science (1983) 1.30
Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res (1990) 1.24
Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol (1987) 1.23
A role for the migrating sperm surface antigen PH-20 in guinea pig sperm binding to the egg zona pellucida. J Cell Biol (1985) 1.22
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res (1994) 1.19
Epidemiological correlations between diet and cancer frequency. Cancer Res (1981) 1.12
Clinical prognostic significance of tumour angiogenesis. Ann Oncol (1994) 1.11
Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm. Proc Natl Acad Sci U S A (1993) 1.09
Proteoglycans and neoplasia. Cancer Metastasis Rev (1988) 1.03
Molecular cloning of the human and monkey sperm surface protein PH-20. Proc Natl Acad Sci U S A (1993) 1.00
Some characteristics of plasma and urine 'hyaluronidase'. J Physiol (1962) 0.95
Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol (1989) 0.94
Characterization of lizard venom hyaluronidase and evidence for its action as a spreading factor. Comp Biochem Physiol B (1983) 0.94
Isolation and characterization of hyaluronidase from scorpion (Heterometrus fulvipes) venom. Biochem Int (1990) 0.87
Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis. Curr Top Microbiol Immunol (1996) 0.87
Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the "fiber hypothesis". Gastroenterology (1984) 0.86
Inhibitory effects of flavonoids on several venom hyaluronidases. Experientia (1991) 0.86
Protective effects of tannic acid and related natural compounds on Crotalus adamenteus subcutaneous poisoning in mice. Pharmacol Toxicol (1993) 0.81
Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Cancer Res (1993) 0.81
A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res (1993) 0.81
The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. Clin Exp Metastasis (1989) 0.80
Inhibition of hyaluronidase by dextran sulfate and its possible application in anticancer treatment. J Cancer Res Clin Oncol (1983) 0.78
Effect of sulfated polysaccharides on blood-borne pulmonary metastasis in rats. Gan (1976) 0.78
Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (1990) 11.18
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
Chromosome partitioning in Escherichia coli: novel mutants producing anucleate cells. J Bacteriol (1989) 5.43
Regulation of the heat-shock response in bacteria. Annu Rev Microbiol (1993) 5.22
Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science (1987) 5.06
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Molecular diversity of the NMDA receptor channel. Nature (1992) 3.76
A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell (1989) 3.70
Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst (1991) 3.40
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol (2001) 3.32
Conversion of diploidy to haploidy. Nature (2000) 3.28
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Mutations of GTBP in genetically unstable cells. Science (1995) 3.23
Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med (1980) 3.21
Escherichia coli FtsH is a membrane-bound, ATP-dependent protease which degrades the heat-shock transcription factor sigma 32. EMBO J (1995) 3.18
Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03
The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol (2000) 2.77
Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res (1992) 2.75
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med (1997) 2.68
Evolutionary instability of operon structures disclosed by sequence comparisons of complete microbial genomes. Mol Biol Evol (1999) 2.68
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62
Localization of actin and myosin for the study of ameboid movement in Dictyostelium using improved immunofluorescence. J Cell Biol (1984) 2.60
Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (1988) 2.59
High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med (1982) 2.56
Structure and function of the F plasmid genes essential for partitioning. J Mol Biol (1986) 2.53
Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers. Br J Vener Dis (1984) 2.50
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
The carboxyl third of tau is tightly bound to paired helical filaments. Neuron (1988) 2.31
Genome plasticity as a paradigm of eubacteria evolution. J Mol Evol (1997) 2.29
Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res (1999) 2.28
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell (1991) 2.24
Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J Cell Biol (1989) 2.24
The Escherichia coli FtsH protein is a prokaryotic member of a protein family of putative ATPases involved in membrane functions, cell cycle control, and gene expression. J Bacteriol (1993) 2.19
Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature (1992) 2.18
Thylakoid DeltapH-dependent precursor proteins bind to a cpTatC-Hcf106 complex before Tha4-dependent transport. J Cell Biol (2001) 2.17
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res (1998) 2.16
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem (1995) 2.15
Observation of the one-dimensional diffusion of nanometer-sized dislocation loops. Science (2007) 2.07
Global metabolic response of Escherichia coli to gnd or zwf gene-knockout, based on 13C-labeling experiments and the measurement of enzyme activities. Appl Microbiol Biotechnol (2003) 2.07
Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05
Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature (1989) 2.04
A new class of microtubule-associated proteins in plants. Nat Cell Biol (2000) 2.00
Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A (1998) 1.98
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96
Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci U S A (1995) 1.89
Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res (2005) 1.88
Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87
Localized fat collection adjacent to the intrahepatic portion of the inferior vena cava: a normal variant on CT. AJR Am J Roentgenol (1992) 1.87
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82
Isolation of temperature-sensitive mutants of 16 S rRNA in Escherichia coli. J Mol Biol (1989) 1.82
Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol (1991) 1.82
Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol (1999) 1.81
Mutations that alter the allosteric nature of cAMP receptor protein of Escherichia coli. EMBO J (1985) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci U S A (1979) 1.73
Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene (1995) 1.67
The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66
p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev (1997) 1.63
Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies. J Exp Med (1979) 1.62
T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J Immunol (1986) 1.62
Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61
Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies. J Bacteriol (1984) 1.59
Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol (1998) 1.58
Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation (2001) 1.58
FADD gene therapy for malignant gliomas in vitro and in vivo. Hum Gene Ther (1998) 1.56
Structure and function of the ftsH gene in Escherichia coli. Res Microbiol (1991) 1.56
Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol (1988) 1.54
Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol (1995) 1.53
Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol (1990) 1.51
Heat shock regulation in the ftsH null mutant of Escherichia coli: dissection of stability and activity control mechanisms of sigma32 in vivo. Mol Microbiol (1998) 1.48
Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies. J Exp Med (1980) 1.48
Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Brain Pathol (1996) 1.47
Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab (1982) 1.47
Polymerase delta variants in RER colorectal tumours. Nat Genet (1995) 1.47
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia (2004) 1.46
Heat induction of sigma 32 synthesis mediated by mRNA secondary structure: a primary step of the heat shock response in Escherichia coli. Nucleic Acids Res (1993) 1.46
Immunocytochemical Analysis Shows that Glyoxysomes Are Directly Transformed to Leaf Peroxisomes during Greening of Pumpkin Cotyledons. Plant Physiol (1986) 1.46
Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon1 subunit. J Neurosci (1998) 1.45
Phosphorylation of tomato 1-aminocyclopropane-1-carboxylic acid synthase, LE-ACS2, at the C-terminal region. J Biol Chem (2001) 1.45
A novel isoenzyme of ascorbate peroxidase localized on glyoxysomal and leaf peroxisomal membranes in pumpkin. Plant Cell Physiol (1995) 1.45
A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res (1996) 1.45
Preparation of antiserum against a tryptic fragment (fragment A) of dynein and an immunological approach to the subunit composition of dynein. J Biol Chem (1975) 1.44
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
F plasmid ccd mechanism in Escherichia coli. J Bacteriol (1986) 1.44
The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis (2001) 1.44
Control of outgrowth and dormancy in axillary buds. Plant Physiol (2001) 1.43
Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet (1997) 1.43